The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 10, 2023
Filed:
Oct. 08, 2015
Applicant:
Xigen Inflammation Ltd., Limassol, CY;
Inventors:
Jean-Marc Combette, Saint Cergues, FR;
Catherine Deloche, Geneva, CH;
Assignee:
XIGEN INFLAMMATION LTD., Limassol, CY;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/05 (2006.01); A61K 38/00 (2006.01); A61K 38/17 (2006.01); C07K 14/47 (2006.01); A61K 9/00 (2006.01); A61K 38/16 (2006.01);
U.S. Cl.
CPC ...
A61K 38/005 (2013.01); A61K 9/0019 (2013.01); A61K 9/0048 (2013.01); A61K 38/16 (2013.01); A61K 38/1709 (2013.01); C07K 14/4703 (2013.01); A61K 38/00 (2013.01); C07K 2319/09 (2013.01); C07K 2319/10 (2013.01); C12N 2710/16711 (2013.01); Y02A 50/30 (2018.01);
Abstract
The present invention refers to the use of protein kinase inhibitors and more specifically to the use of inhibitors of the protein kinase c-Jun amino terminal kinase, JNK inhibitor sequences, chimeric peptides, or of nucleic acids encoding same as well as pharmaceutical compositions containing same, for the treatment of various diseases or disorders strongly related to JNK signaling.